Fujian Aonong Biological Technology Grouporp (SHSE:603363) Total Inventories: ¥1,162 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603363 Fujian Aonong Biological Technology Group Incorp Ltd SHSE:603363
31 GF Score
Price ¥2.67
GF Value ¥1.32
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Fujian Aonong Biological Technology Grouporp Total Inventories?

Fujian Aonong Biological Technology Grouporp SHSE:603363 -3.96% 31 Total Inventories is ¥1,162 Mil as of Mar. 2026. GuruFocus rates SHSE:603363 with a GF Score™ of 31/100 and a GF Value™ of ¥1.32 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Fujian Aonong Biological Technology Grouporp's total inventories for the quarter that ended in Mar. 2026 was ¥1,162 Mil. Fujian Aonong Biological Technology Grouporp's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was ¥1,059 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Fujian Aonong Biological Technology Grouporp's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was ¥-1.61.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Fujian Aonong Biological Technology Grouporp's Days Inventory for the three months ended in Mar. 2026 was 45.74.

Inventory Turnover measures how fast the company turns over its inventory within a year. Fujian Aonong Biological Technology Grouporp's Inventory Turnover for the quarter that ended in Mar. 2026 was 2.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Fujian Aonong Biological Technology Grouporp's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.48.


Fujian Aonong Biological Technology Grouporp  (SHSE:603363) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Fujian Aonong Biological Technology Grouporp's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is

Net-Net Working Capital Per Share (Q: Mar. 2026 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(440.855+0.75 * 718.862+0.5 * 1161.837-5341.03
-0-411.789)/2602.962
=-1.61

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Fujian Aonong Biological Technology Grouporp's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2026 )/Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=1058.619/2112.068*365 / 4
=45.74

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Fujian Aonong Biological Technology Grouporp's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2026 ) / Average Total Inventories (Q: Mar. 2026 )
=2112.068 / 1058.619
=2.00

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Fujian Aonong Biological Technology Grouporp's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=1058.619 / 2205.837
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Fujian Aonong Biological Technology Grouporp Total Inventories Related Terms


Fujian Aonong Biological Technology Grouporp Total Inventories Historical Data

* Premium members only.

The historical data trend for Fujian Aonong Biological Technology Grouporp's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fujian Aonong Biological Technology Grouporp Total Inventories Chart

Fujian Aonong Biological Technology Grouporp Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,588.85 3,288.70 1,328.14 816.94 955.40

Fujian Aonong Biological Technology Grouporp Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 834.54 905.90 887.77 955.40 1,161.84
SHSE:603363
31GF Score
Fujian Aonong Biological Technology Group Incorp Ltd SHSE:603363
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fujian Aonong Biological Technology Grouporp Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of ¥1,162 Mil mean?
Fujian Aonong Biological Technology Grouporp (SHSE:603363) has a Total Inventories of ¥1,162 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Fujian Aonong Biological Technology Grouporp and its competitors.
Is Fujian Aonong Biological Technology Grouporp's Total Inventories too high?
Fujian Aonong Biological Technology Grouporp's current Total Inventories is ¥1,162 Mil. Overall, Fujian Aonong Biological Technology Grouporp has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fujian Aonong Biological Technology Grouporp's Total Inventories compare to ADM and BG?
Fujian Aonong Biological Technology Grouporp's Total Inventories of ¥1,162 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Consumer Packaged Goods company?
A good Total Inventories depends on the Consumer Packaged Goods industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Fujian Aonong Biological Technology Grouporp and its competitors. Fujian Aonong Biological Technology Grouporp's current Total Inventories is ¥1,162 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fujian Aonong Biological Technology Grouporp stock overvalued right now?
Based on GuruFocus' analysis, Fujian Aonong Biological Technology Grouporp (SHSE:603363) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.32, compared to a current price of ¥2.67 — trading 102.3% above its estimated fair value. The current Total Inventories is ¥1,162 Mil. Fujian Aonong Biological Technology Grouporp's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Fujian Aonong Biological Technology Grouporp (SHSE:603363), the current Total Inventories is ¥1,162 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fujian Aonong Biological Technology Grouporp (SHSE:603363) Overvalued in 2026?

Based on GuruFocus' analysis, Fujian Aonong Biological Technology Grouporp stock appears to be overvalued. The current stock price of ¥2.67 is trading 102.3% above its estimated GF Value™ of ¥1.32. GuruFocus considers Fujian Aonong Biological Technology Grouporp to be Significantly Overvalued.

Key valuation signals for SHSE:603363:

  • Total Inventories: ¥1,162 Mil
  • GF Value™: ¥1.32 vs. price of ¥2.67 (102.3% above fair value)
  • GF Score™: 31/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fujian Aonong Biological Technology Grouporp Business Description

Address Guanyinshan Operation Center, 12th Floor, Building 10, Siming District, Fujian Province, Xiamen, CHN, 361008
Fujian Aonong Biological Technology Group Incorp Ltd is an agricultural and animal husbandry enterprise in China. The principal business activities of the company include feed-oriented service, animal protection, pig raising, and raw material trade. In addition, the company's insurance business mainly relies on the feed marketing system throughout the country to provide downstream farmers with relevant products for disease prevention and control.
31GF Score

Get the complete analysis for SHSE:603363

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥2.67
Price
¥1.32
GF Value